Free Trial
→ Market down? Do this now. (From Colonial Metals) (Ad) Free SRPT Stock Alerts

Sarepta Therapeutics (SRPT) SEC Filings & 10K Form

Sarepta Therapeutics logo
$106.28 -2.13 (-1.96%)
Closing price 04:00 PM Eastern
Extended Trading
$106.22 -0.06 (-0.06%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Sarepta Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
12:32 PM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:38 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
7:30 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
11:25 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:06 PM		Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:18 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:15 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/26/2024
6:17 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:40 AM		JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
11/13/2024
9:27 AM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
09/16/2024
7:00 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2024
7:05 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:51 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
4:03 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:00 AM		Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:50 PM		Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:01 PM		Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:35 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:16 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
3:45 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
12:30 PM		BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
05/06/2024
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/06/2024
7:09 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Alert: DOGE goes live (Ad)

"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.

Click here to learn more.
05/01/2024
3:01 PM		Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM		Sarepta Therapeutics (Filer)
Form DEF 14A
03/11/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:02 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
6:03 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:38 PM		Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM		Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:34 PM		Mayo Stephen (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
6:55 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
6:42 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:47 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SRPT) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...
Altimetry | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored